{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:06:09Z","timestamp":1783595169378,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":1384,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"The Paul I Terasaki Memorial Research Fund"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1111\/ajt.15007","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T03:37:15Z","timestamp":1530934635000},"page":"381-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4827-6885","authenticated-orcid":false,"given":"David F.","family":"Pinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"Zachary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9344-9928","authenticated-orcid":false,"given":"John J.","family":"Friedewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Gjertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik N.","family":"Chatroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Leffell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley A.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley C.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat R.","family":"Tambur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1111\/ajt.15007_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MOT.0000000000000262","article-title":"Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts","volume":"21","author":"Baldwin","year":"2016","journal-title":"Curr Opin Organ Transplant."},{"issue":"7","key":"10.1111\/ajt.15007_bib2","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1681\/ASN.2014080837","article-title":"Utility of HLA antibody testing in kidney transplantation","volume":"26","author":"Konvalinka","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"10.1111\/ajt.15007_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1600-6143.2011.03525.x","article-title":"Summary of FDA antibody-mediated rejection workshop","volume":"11","author":"Archdeacon","year":"2011","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.15007_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/TP.0000000000000315","article-title":"Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays","volume":"98","author":"Visentin","year":"2014","journal-title":"Transplantation."},{"issue":"1S Suppl 1","key":"10.1111\/ajt.15007_bib5","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/TP.0000000000001817","article-title":"HLA diagnostics: Evaluating DSA strength by titration","volume":"102","author":"Tambur","year":"2018","journal-title":"Transplantation."},{"issue":"9","key":"10.1111\/ajt.15007_bib6","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: Comparison of MFI, C1q, and titer information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.15007_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.healun.2015.01.982","article-title":"Reduced HLA class II antibody response to proteasome inhibition in heart transplantation","volume":"34","author":"Khuu","year":"2015","journal-title":"J Heart Lung Transplant."},{"key":"10.1111\/ajt.15007_bib8","article-title":"Changes in IgG subclasses of donor specific anti-HLA antibodies following bortezomib-based therapy for antibody mediated rejection","volume":"229\u2013235","author":"Kannabhiran","year":"2012","journal-title":"Clin Transpl."},{"issue":"10","key":"10.1111\/ajt.15007_bib9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/01.TP.0000090868.88895.E0","article-title":"Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients","volume":"76","author":"Zachary","year":"2003","journal-title":"Transplantation."},{"issue":"4","key":"10.1111\/ajt.15007_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/trf.12923","article-title":"Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients","volume":"55","author":"Yamada","year":"2015","journal-title":"Transfusion."},{"issue":"6","key":"10.1111\/ajt.15007_bib11","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1097\/TP.0000000000002141","article-title":"Summary OF 2017 FDA public workshop: antibody mediated rejection in kidney transplantation","volume":"102","author":"Velidedeoglu","year":"2018","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15007_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-61779-842-9_17","article-title":"HLA antibody detection and characterization by solid phase immunoassays: methods and pitfalls","volume":"882","author":"Zachary","year":"2012","journal-title":"Methods Mol Biol."},{"issue":"1S suppl 1","key":"10.1111\/ajt.15007_bib13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001818","article-title":"Of Cells and Microparticles: assets and liabilities of HLA antibody detection","volume":"102","author":"Liwski","year":"2018","journal-title":"Transplantation."},{"issue":"6","key":"10.1111\/ajt.15007_bib14","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure","volume":"12","author":"Otten","year":"2012","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.15007_bib15","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"12","key":"10.1111\/ajt.15007_bib16","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.15007_bib17","unstructured":"LABScreen Product Insert. One Lambda Inc, A Thermo Fisher Scientific Brand. 2017. http:\/\/www.onelambda.com\/content\/dam\/onelambda\/en\/TDX\/Documents\/securedocs\/docs\/Product_Insert\/LS-LSCN-PI-EN-00.pdf. Accessed July 26, 2018."},{"issue":"11","key":"10.1111\/ajt.15007_bib18","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1111\/ajt.12462","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.15007_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/TP.0b013e3181c6ff8d","article-title":"Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection","volume":"89","author":"Walsh","year":"2010","journal-title":"Transplantation."},{"issue":"12","key":"10.1111\/ajt.15007_bib20","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":"Reduction of alloantibodies via proteasome inhibition in cardiac transplantation","volume":"30","author":"Patel","year":"2011","journal-title":"J Heart Lung Transplant."},{"issue":"8","key":"10.1111\/ajt.15007_bib21","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1600-6143.2011.03560.x","article-title":"Mastering the risk of HLA antibodies in kidney transplantation: an algorithm based on pretransplant single-antigen flow bead techniques","volume":"11","author":"Lefaucheur","year":"2011","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.15007_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/TP.0b013e31822872dd","article-title":"HLA antibody specification using single-antigen beads \u2013 a technical solution for the prozone effect","volume":"92","author":"Schnaidt","year":"2011","journal-title":"Transplantation."},{"issue":"7","key":"10.1111\/ajt.15007_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2009.04.001","article-title":"Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution","volume":"70","author":"Zachary","year":"2009","journal-title":"Hum Immunol."},{"issue":"3","key":"10.1111\/ajt.15007_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med."},{"issue":"8","key":"10.1111\/ajt.15007_bib25","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1034\/j.1600-6143.2003.00180.x","article-title":"Overcoming a positive crossmatch in living-donor kidney transplantation","volume":"3","author":"Gloor","year":"2003","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.15007_bib26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation."},{"issue":"8","key":"10.1111\/ajt.15007_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.humimm.2016.05.025","article-title":"Can solid phase assays be better utilized to measure efficacy of antibody removal therapies?","volume":"77","author":"Tambur","year":"2016","journal-title":"Hum Immunol."},{"issue":"2","key":"10.1111\/ajt.15007_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2006.09.001","article-title":"Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model","volume":"122","author":"Kim","year":"2007","journal-title":"Clin Immunol."},{"issue":"5278","key":"10.1111\/ajt.15007_bib29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/2281304a0","article-title":"Stimulation of proliferation of 19S antibody-forming cells in the spleens of immunized guinea pigs after exchange transfusion","volume":"228","author":"Sturgill","year":"1970","journal-title":"Nature."},{"issue":"1\u20132","key":"10.1111\/ajt.15007_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-1759(85)90438-7","article-title":"Membrane plasmapheresis technique in rats. Confirmation of antibody rebound","volume":"84","author":"Euler","year":"1985","journal-title":"J Immunol Methods."},{"issue":"6","key":"10.1111\/ajt.15007_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1537-2995.1975.15676082232.x","article-title":"Plasma exchange in the treatment of immune disease","volume":"15","author":"Branda","year":"1975","journal-title":"Transfusion."},{"issue":"1","key":"10.1111\/ajt.15007_bib32","first-page":"35","article-title":"Rebound and overshoot after plasma exchange in humans","volume":"104","author":"Derksen","year":"1984","journal-title":"J Lab Clin Med."},{"issue":"3","key":"10.1111\/ajt.15007_bib33","first-page":"457","article-title":"The effect of extracorporeal antibody removal on antibody synthesis and catabolism in immunized rabbits","volume":"60","author":"Charlton","year":"1985","journal-title":"Clin Exp Immunol."},{"issue":"21","key":"10.1111\/ajt.15007_bib34","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"Gelfand","year":"2012","journal-title":"N Engl J Med."},{"issue":"11","key":"10.1111\/ajt.15007_bib35","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/TP.0b013e318218e901","article-title":"Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition","volume":"91","author":"Walsh","year":"2011","journal-title":"Transplantation."},{"issue":"5","key":"10.1111\/ajt.15007_bib36","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.humimm.2013.01.008","article-title":"Significant IgG subclass heterogeneity in HLA-specific antibodies: Implications for pathogenicity, prognosis, and the rejection response","volume":"74","author":"Lowe","year":"2013","journal-title":"Hum Immunol."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15007","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522089419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522089419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.15007\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:24:04Z","timestamp":1761629044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522089419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1600613522089419"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15007","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}